<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Haack PA</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>e202212946</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10100342</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>61(52)</volume><pubmed_abstract>During our search for novel myxobacterial natural products, we discovered the thiamyxins: thiazole- and thiazoline-rich non-ribosomal peptide-polyketide hybrids with potent antiviral activity. We isolated four congeners of this unprecedented natural product family with the non-cyclized thiamyxin D fused to a glycerol unit at the C-terminus. Alongside their structure elucidation, we present a concise biosynthesis model based on biosynthetic gene cluster analysis and isotopically labelled precursor feeding. We report incorporation of a 2-(hydroxymethyl)-4-methylpent-3-enoic acid moiety by a GCN5-related N-acetyltransferase-like decarboxylase domain featuring polyketide synthase. The thiamyxins show potent inhibition of RNA viruses in cell culture models of corona, zika and dengue virus infec</pubmed_abstract><journal>Angewandte Chemie (International ed. in English)</journal><pubmed_title>Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors.</pubmed_title><pmcid>PMC10100342</pmcid><funding_grant_id>EXC 2155 - project number 390874280</funding_grant_id><pubmed_authors>Voltz A</pubmed_authors><pubmed_authors>Harmrolfs K</pubmed_authors><pubmed_authors>Haid S</pubmed_authors><pubmed_authors>Popoff A</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Gunesch AP</pubmed_authors><pubmed_authors>Muller R</pubmed_authors><pubmed_authors>Garcia R</pubmed_authors><pubmed_authors>Haack PA</pubmed_authors><pubmed_authors>Bader CD</pubmed_authors><pubmed_authors>Pietschmann T</pubmed_authors><pubmed_authors>Bartenschlager R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors.</name><description>During our search for novel myxobacterial natural products, we discovered the thiamyxins: thiazole- and thiazoline-rich non-ribosomal peptide-polyketide hybrids with potent antiviral activity. We isolated four congeners of this unprecedented natural product family with the non-cyclized thiamyxin D fused to a glycerol unit at the C-terminus. Alongside their structure elucidation, we present a concise biosynthesis model based on biosynthetic gene cluster analysis and isotopically labelled precursor feeding. We report incorporation of a 2-(hydroxymethyl)-4-methylpent-3-enoic acid moiety by a GCN5-related N-acetyltransferase-like decarboxylase domain featuring polyketide synthase. The thiamyxins show potent inhibition of RNA viruses in cell culture models of corona, zika and dengue virus infec</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-06-05T06:48:33.495Z</modification><creation>2025-02-18T23:40:43.347Z</creation></dates><accession>S-EPMC10100342</accession><cross_references><pubmed>36208117</pubmed><doi>10.1002/anie.202212946</doi></cross_references></HashMap>